GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection
Analytical Chemistry · 30.10.2026
DOI: 10.1021/acs.analchem.6c05407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 30.10.2026. Verfasst von Wenyang Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, Riverside92521, California, United States. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, SARS-CoV-2, G-Quadruplexes, COVID-19. Die Arbeit nennt 38 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of Food and Agriculture, National Institute of General Medical Sciences.
Abstract (Originalsprache)
SARS-CoV-2 remains a serious public health threat, highlighting the need for rapid and accessible nucleic-acid diagnostics for decentralized testing. CRISPR-Cas systems are promising platforms for viral diagnostics because of their high specificity and compatibility with isothermal workflows. However, many CRISPR-based assays still rely on labelled reporters, dedicated fluorescence instrumentation, or single-mode outputs that increase cost and limit field deployment. Herein, we developed a label-free GLOW-CRISPR assay (a G-quadruplex loop-engineered optical workflow combined with the CRISPR-Cas12a system) to detect SARS-CoV-2. The assay provides fluorescence and colorimetric readouts in separate endpoint workflows through loop-engineered G4 reporters. Upon recognition of the SARS-CoV-2 target, activated Cas12a cleaves the loop-engineered G4 reporters, thereby suppressing both fluorescence and colorimetric signals. Using optimized conditions, the GLOW-CRISPR assay achieved limits of detection of 7.7 nM and 2.9 nM for fluorescence and colorimetric readouts, respectively. It also showed no detectable cross-reactivity with non-target respiratory viruses and correctly classified patient-derived nasopharyngeal samples in concordance with RT-qPCR results. Collectively, these results establish G4 loop engineering as a general strategy for label-free CRISPR-Cas12a signal transduction without probe labelling or specialized instrumentation. By expanding optical readout flexibility while reducing assay cost and complexity, the GLOW-CRISPR assay provides a practical framework for decentralized molecular diagnostics in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of California, Riverside92521, California, United States.
- Department of Microbiology, Immunology & Tropical Medicine, School of Medicine and Health Sciences, George Washington University, Washington20037, District of Columbia, United States.
- The District of Columbia Center for AIDS Research, Washington20052, District of Columbia, United States.
ORCID-Profile: Xiaodong Lin, Xiang Li, Tathagata Pal, Juhong Chen
Förderung
- NIGMS NIH HHS
- National Institute of Food and Agriculture
- National Institute of General Medical Sciences
Zitieren
APA
Shi, W., Lin, X., Li, X., Pal, T., Liu, B. M., & Chen, J. (2026). GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c05407
Vancouver
Shi W, Lin X, Li X, Pal T, Liu BM, Chen J. GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c05407
BibTeX
@article{Shi2026,
author = {Shi, Wenyang and Lin, Xiaodong and Li, Xiang and Pal, Tathagata and Liu, Benjamin M and Chen, Juhong},
title = {GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c05407}
}
EUVIMED